FPRX - Five Prime Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue49,86839,50830,691379,801
Cost of Revenue156,352150,90894,07270,197
Gross Profit-106,484-111,400-63,381309,604
Operating Expenses
Research Development-150,908150,908150,908
Selling General and Administrative39,67140,00235,83122,631
Non Recurring----
Others----
Total Operating Expenses196,023190,910129,90392,828
Operating Income or Loss-146,155-151,402-99,212286,973
Income from Continuing Operations
Total Other Income/Expenses Net5,7082,8842,467484
Earnings Before Interest and Taxes-146,155-151,402-99,212286,973
Interest Expense----
Income Before Tax-140,447-148,518-96,745287,457
Income Tax Expense-1,704-31,04837,810
Minority Interest----
Net Income From Continuing Ops-140,447-150,222-65,697249,647
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-140,447-150,222-65,697249,647
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-140,447-150,222-65,697249,647